Brain injury
Publisher:
Taylor & Francis,. London : Informa Healthcare
Frequency: Fourteen no. a year, 2005-
Country: England
Language: English
Start Year:1987 -
ISSN:
0269-9052 (Print)
1362-301X (Electronic)
0269-9052 (Linking)
1362-301X (Electronic)
0269-9052 (Linking)
Impact Factor
1.9
2022
| NLM ID: | 8710358 |
| (DNLM): | SR0054784(s) |
| (OCoLC): | 12055327 |
| Coden: | BRAIEO |
| LCCN: | 88659556 |
| Classification: | W1 BR113E |
Early use of Xeomin neurotoxin for local anti-spasticity therapy for pes equines after acquired brain injury (ABI). The acute management of spasticity following ABI is challenging. Contractures can occur during the acute phases of illness. The joints most affected are the shoulders and the ankles. Methods: A case study of a 48-year-old female patient who received local chemoneurolytic anti-spasticity therapy following a severe subarachnoid haemorrhage for pes equines deformity is presented to illustrate the role of focal neurotoxin therapy. Methods: The increasing spasticity in her legs was observed and could not be effectively treated with oral anti-spasticity agents or intensive physiotherapy. As spastici...